Earnings Scheduled For March 17, 2014 - Acorn Energy (OTC:ACFN), Ares Comml Real Est (NYSE:ACRE)

JA Solar Holdings Co

JASO

is projected to report its Q4 earnings at $0.01 per share on revenue of $291.82 million. Consolidated Water Co

CWCO

is estimated to post its Q4 earnings at $0.08 per share on revenue of $16.34 million. LATAM Airlines Group SA

LFL

is projected to post its Q4 earnings at $0.15 per share on revenue of $3.45 billion. Ares Commercial Real Estate

ACRE

is expected to report its Q4 earnings at $0.20 per share on revenue of $8.72 million. Sterling Construction Co

STRL

is projected to post a Q4 loss at $1.47 per share on revenue of $153.07 million. FutureFuel

is expected to post its Q4 earnings at $0.23 per share on revenue of $75.15 million. Global Power Equipment Group

GLPW

is projected to post its Q4 earnings at $0.37 per share on revenue of $136.93 million. Harvest Natural Resources

HNR

is estimated to report its Q4 earnings at $0.10 per share. LMI Aerospace

LMIA

is estimated to report its Q4 earnings at $0.04 per share on revenue of $104.47 million. Towerstream

TWER

is projected to post a Q4 loss at $0.10 per share on revenue of $8.58 million. Galena Biopharma

GALE

is expected to post a Q4 loss at $0.09 per share on revenue of $1.62 million. Acorn Energy

ACFN

is projected to post a Q4 loss at $0.23 per share on revenue of $6.03 million. Health Insurance Innovations

HIIQ

is expected to post its Q4 earnings at $0.07 per share on revenue of $15.65 million. Genie Energy

GNE

is estimated to post a Q4 loss at $0.05 per share on revenue of $68.05 million. Tsakos Energy Navigation

TNP

is expected to post a Q4 loss at $0.09 per share on revenue of $74.63 million. Inovio Pharmaceuticals

INO

is projected to post a Q4 loss at $0.03 per share on revenue of $1.36 million. OFS Capital

OFS

is expected to report its Q4 earnings at $0.15 per share on revenue of $4.41 million. Apricus Biosciences

APRI

is estimated to post a Q4 loss at $0.06 per share on revenue of $2.00 million. Yongye International

YONG

is projected to report its Q4 earnings. Pernix Therapeutics Holdings

PTX

is estimated to post a Q4 loss at $0.10 per share on revenue of $23.82 million.